These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27871742)

  • 1. New poliovirus vaccine schedules.
    Zhang Q; Leppold C; Shao Y; Mura Y; Tanimoto T
    Lancet; 2016 Nov; 388(10059):2477-2478. PubMed ID: 27871742
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine.
    Guérin N; Bregère P; Caudrelier P; Raynaud O
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):815-6. PubMed ID: 9923532
    [No Abstract]   [Full Text] [Related]  

  • 3. The final phase of polio eradication: new vaccines and complex choices.
    Cochi SL; Linkins RW
    J Infect Dis; 2012 Jan; 205(2):169-71. PubMed ID: 22158681
    [No Abstract]   [Full Text] [Related]  

  • 4. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The final stages of the global eradication of polio.
    John TJ
    N Engl J Med; 2000 Sep; 343(11):806-7. PubMed ID: 10984572
    [No Abstract]   [Full Text] [Related]  

  • 8. Low oral poliovirus vaccine immunogenicity in developing countries.
    Orenstein WA; Garon JR
    Lancet Infect Dis; 2016 Aug; 16(8):868-9. PubMed ID: 27156190
    [No Abstract]   [Full Text] [Related]  

  • 9. Poliovirus vaccination.
    John TJ
    Lancet; 1993 Aug; 342(8867):370-1. PubMed ID: 8101609
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid and accurate identification of poliovirus strains used for vaccine production.
    Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
    J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.
    Bandyopadhyay AS; Asturias EJ; O'Ryan M; Oberste MS; Weldon W; Clemens R; Rüttimann R; Modlin JF; Gast C
    Vaccine; 2017 Dec; 35(52):7283-7291. PubMed ID: 29150209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO policy statement on polio vaccines.
    Wkly Epidemiol Rec; 1995 Dec; 70(49):346-7. PubMed ID: 8652353
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanded programme on immunization. Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population.
    Wkly Epidemiol Rec; 1992 Jun; 67(24):179-82. PubMed ID: 1319191
    [No Abstract]   [Full Text] [Related]  

  • 14. The outbreak of poliomyelitis in Finland in 1984-1985: significance of antigenic variation of type 3 polioviruses and site specificity of antibody responses in antipolio immunizations.
    Hovi T
    Adv Virus Res; 1989; 37():243-75. PubMed ID: 2557759
    [No Abstract]   [Full Text] [Related]  

  • 15. New recommendations for poliovirus vaccination. Combination regimen captures best effects of available vaccines.
    Conrad DA; Jenson HB
    Postgrad Med; 1997 Nov; 102(5):45-8, 51-3, 59-60 passim. PubMed ID: 9385331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving and maintaining polio eradication--new strategies.
    Modlin J; Wenger J
    N Engl J Med; 2014 Oct; 371(16):1476-9. PubMed ID: 25317869
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparing the immunogenicity and safety of sequential inoculation of sIPV followed by bOPV (Ⅰ+Ⅲ) in different dosage forms].
    Ye H; Huang T; Ying ZF; Li GL; Che YC; Zhao ZM; Wang JF; Yang XL; Shi L; Jiang RJ; Liu XC; Mo ZJ; Li CG; Yang JS
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):43-49. PubMed ID: 29334707
    [No Abstract]   [Full Text] [Related]  

  • 18. Poliomyelitis immunity status in Italian and foreign subjects.
    Tanzi ML; Bracchi U; Affanni P; Dall'Argine A; Bombarda G; Bellelli E
    Ann Ig; 1992; 4(4):191-7. PubMed ID: 1284576
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody response of children immunized with poliovaccines: an evaluation using two strains of poliovirus type 1.
    Deshpande JM; Dave KH
    Indian J Med Res; 1992 Sep; 95():216-20. PubMed ID: 1335965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection.
    Ogra PL; Karzon DT; Righthand F; MacGillivray M
    N Engl J Med; 1968 Oct; 279(17):893-900. PubMed ID: 20617594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.